These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29781401)

  • 21. MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.
    Lim EL; Trinh DL; Ries RE; Wang J; Gerbing RB; Ma Y; Topham J; Hughes M; Pleasance E; Mungall AJ; Moore R; Zhao Y; Aplenc R; Sung L; Kolb EA; Gamis A; Smith M; Gerhard DS; Alonzo TA; Meshinchi S; Marra MA
    J Clin Oncol; 2017 Dec; 35(35):3964-3977. PubMed ID: 29068783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias.
    Riccioni R; Lulli V; Castelli G; Biffoni M; Tiberio R; Pelosi E; Lo-Coco F; Testa U
    Leuk Res; 2015 Feb; 39(2):221-8. PubMed ID: 25543261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of prognostic miRNA biomarkers for predicting overall survival of colon adenocarcinoma and bioinformatics analysis: A study based on The Cancer Genome Atlas database.
    Chen F; Li Z; Zhou H
    J Cell Biochem; 2019 Jun; 120(6):9839-9849. PubMed ID: 30536901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J
    Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia.
    Niu P; Yao B; Wei L; Zhu H; Fang C; Zhao Y
    Blood Cells Mol Dis; 2019 Jul; 77():43-50. PubMed ID: 30954792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
    Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
    Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
    Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML.
    Sun SM; Rockova V; Bullinger L; Dijkstra MK; Döhner H; Löwenberg B; Jongen-Lavrencic M
    Leukemia; 2013 Jan; 27(1):100-6. PubMed ID: 22692398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-depth characterization of the microRNA transcriptome in a leukemia progression model.
    Kuchenbauer F; Morin RD; Argiropoulos B; Petriv OI; Griffith M; Heuser M; Yung E; Piper J; Delaney A; Prabhu AL; Zhao Y; McDonald H; Zeng T; Hirst M; Hansen CL; Marra MA; Humphries RK
    Genome Res; 2008 Nov; 18(11):1787-97. PubMed ID: 18849523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a/b in acute myelocytic leukemia.
    Zhao TF; Jia HZ; Zhang ZZ; Zhao XS; Zou YF; Zhang W; Wan J; Chen XF
    Mol Med Rep; 2017 Sep; 16(3):3687-3693. PubMed ID: 28765931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.
    Luo W; Wang L; Luo MH; Huang YZ; Yang H; Zhou Y; Jia HT; Wang XX
    J Cell Biochem; 2017 Oct; 118(10):3488-3494. PubMed ID: 28338236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory Networks of Prognostic mRNAs in Pediatric Acute Myeloid Leukemia.
    Zhang H; Cheng L; Liu C
    J Healthc Eng; 2022; 2022():2691997. PubMed ID: 35035819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
    Zhang S; Zhang Q; Shi G; Yin J
    Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
    Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y
    Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.